Search
world_patient_safety_day.pdf
PatientPoll_infographic_final.pdf
Payments_to_patienten_organisations_2020.pdf
Payments_to_patienten_organisations_2022
Patient advocacy tips for cancer
Harold_and_Dorothy_Patient_Discussion_Guide_Factsheet_0.pdf
What is Pharmacovigilance & its role on Patient Safet.pdf
Stakeholders in Patient Safety & Pharmacovigilance.pdf
COPD Patient brochure
Leistungen an Patientenorganisationen 2023
Payments to patient organisations 2023
What is pharmacovigilance & its role on patient safety
What is being done for patient safety by different stakeholder
Payments to patient organizations
What is pharmacovigilance & its role on patient safety
Biostatistics & Data Science
Discover how we use data science methods on clinical trials data to develop patient-led innovations and breakthrough treatments.
Spesolimab prevents GPP flares
Spesolimab prevents generalized pustular psoriasis flares in EFFISAYIL™ 2 trial
Translational Medicine & Clinical Pharmacology
We connect the right patient with the right drug on the right dosing schedule using data science methods from pharmacometrics to systems pharmacology.
Scleroderma Life Hacks
Video series featuring people living with scleroderma using everyday items in different ways to help them manage their symptoms. Part of the global 'More Than Scleroderma' initiative developed by Boehringer Ingelheim, with support from patient organi
What are acute exacerbations in IPF?
Risk factors for acute exacerbations in IPF are unclear, but there is evidence that a number of factors may increase risk. Learn more here.
SPEVIGO approved expanded indications China US
SPEVIGO® approved for expanded indications in China and the US
U.S. FDA approves first treatment for generalized pustular psoriasis flares in adults
Boehringer Ingelheim announces the U.S. FDA has approved the first treatment for generalized pustular psoriasis (GPP) flares in adults
Embracing diversity in clinical trials
At Boehringer Ingelheim, we understand the crucial need of embracing diversity in clinical trials as an opportunity to enable more equitable healthcare.
The generalized pustular psoriasis (GPP) Forum 2023
An executive summary of the activities and key takeaways from the GPP Forum 2023